News | July 14, 2008

Epocrates Drug, Formulary Application Available for iPhone, iPod

July 15, 2008 - Epocrates Inc. announced that its mobile drug and formulary reference, reportedly used by more than 500,000 healthcare professionals, can be downloaded free for the iPhone and iPod touch from the Apple App Store after Epocrates registration.

In addition, for the first time, the Epocrates Rx mobile application will feature pill pictures and a drug identification tool, providing more visual cues and resources for today's busy physicians. With enhanced functionality, clinicians can show their patients pictures of a newly prescribed drug, or identify a patient's existing medication with a physical description (e.g., round, blue and scored) when the name cannot be recalled.

"I believe Epocrates on the iPhone is an essential tool for the medical community - it is the one native application most healthcare professionals cannot live without," said Dr. Michael Salesin, Wayne State University School of Medicine. "Many of my colleagues have been waiting for the Epocrates application before purchasing the iPhone. I guarantee it's going to be the first download on many devices, and immediately put to use with patients."

Epocrates software is used by clinicians worldwide to reference a host of drug information, such as dosing, interactions and health plan coverage.

The Epocrates free application is available from Apple's App Store on iPhone and iPod touch or at www.itunes.com/appstore.

For more information: www.epocrates.com/company


Additional Content

News | Pharmaceuticals

July 16, 2026 — Merck has received U.S. Food and Drug Administration (FDA) approval for Lipfendra (enlicitide) tablets ...

Home July 16, 2026
Home
News | Pharmaceuticals

Jan. 27, 2026 — Cytokinetics, Inc. has announced that Myqorzo (aficamten) is now available for prescription in 5 mg, 10 ...

Home January 28, 2026
Home
News | Pharmaceuticals

Nov. 19, 2025 — Promising results from a pivotal Phase 3 clinical trial of an investigational heart-attack drug were ...

Home November 19, 2025
Home
News | Pharmaceuticals

Sept. 25, 2025 — Kardigan has introduced the three late-stage clinical programs leading its robust pipeline, each ...

Home September 25, 2025
Home
News | Pharmaceuticals

Sept. 23, 2025 — CeleCor Therapeutics’ multinational Phase 3 clinical trial of its investigational heart-attack drug ...

Home September 23, 2025
Home
Subscribe Now